Life Science Session 1: Parallel Trade in Life Sciences
24/11/2020 13:30 24/11/2020 14:30 (Europe/Brussels)
Please join us for the first of our Life Sciences Sessions updating you on the most essential developments in the life sciences field in Europe.
The COVID-19 pandemic challenges companies and firms worldwide, and requires us all to adopt new proactive approaches. While COVID-19 prevents us from being together, our Life Sciences team takes the initiative to give you short, digestible and regular online Life Sciences Sessions.
In our first Life Sciences Session, our experts Philippe de Jong and Kirian Claeyé will talk you through a number of recent decisions and developments in the field of parallel trade of pharmaceuticals, medical devices and plant protection products, including:
- The rebranding of generics to original brand reference products
- The impact of the falsified medicines framework on parallel trade
- Further points of attention when verifying in light of the BMS conditions